Clinical Trial Update: TDM Guided Early Optimization of ADAL in Crohn's Disease [NA]

View source ↗

Summary

Clinical trial NCT03261102 is evaluating therapeutic drug monitoring-guided early optimization of adalimumab in Crohn's disease. The study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: waqqas.afif | Conditions: Crohn Disease, Drug Monitoring | NA | Status: ACTIVE_NOT_RECRUITING